Robert W. Duggan - 02 Jan 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
02 Jan 2024
Net transactions value
+$98,399
Form type
4
Filing time
04 Jan 2024, 16:16:45 UTC
Previous filing
14 Dec 2023
Next filing
24 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award $98,399 +74,545 $1.32 74,545 02 Jan 2024 Common Stock 74,545 $2.64 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 following election, subject to the reporting person remaining as a non-salaried director on each such vesting date.
F2 The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $98,400.